The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hepatitis B Human Immunoglobulin Market Research Report 2025
Synopsis
The global Hepatitis B Human Immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Hepatitis B Human Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hepatitis B Human Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hepatitis B Human Immunoglobulin include Biotest, ADMA Biologics, Sanquin Blood, Bio Products Laboratory, Baxter, CSL, Bayer, Grifols and Octapharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Human Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Human Immunoglobulin.
Report Scope
The Hepatitis B Human Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Human Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Human Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biotest
ADMA Biologics
Sanquin Blood
Bio Products Laboratory
Baxter
CSL
Bayer
Grifols
Octapharma
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Shanghai Institute of Biological
Hualan
Shanghai RAAS Blood Products
China Grand Enterprises
Nanyue Biopharmaceutical
Boya Biopharmaceutical Group
Tonglu Biopharmaceutical
Shandong Taibang Biopharmaceutical
Guangdong Shuanglin Biopharmaceutical
Chengdu Rongsheng Pharmaceutical
Shenzhen Weiguang Biopharmaceutical
Green Cross (China) Biological Products
Sinopharm
Segment by Type
100IU
200IU
400IU
Segment by Application
Measles Prevention
Prevention of Hepatitis B Virus Infection
Hepatitis A Virus Infection
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Human Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Human Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Hepatitis B Human Immunoglobulin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Hepatitis B Human Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hepatitis B Human Immunoglobulin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hepatitis B Human Immunoglobulin include Biotest, ADMA Biologics, Sanquin Blood, Bio Products Laboratory, Baxter, CSL, Bayer, Grifols and Octapharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Human Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Human Immunoglobulin.
Report Scope
The Hepatitis B Human Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Human Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Human Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biotest
ADMA Biologics
Sanquin Blood
Bio Products Laboratory
Baxter
CSL
Bayer
Grifols
Octapharma
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Shanghai Institute of Biological
Hualan
Shanghai RAAS Blood Products
China Grand Enterprises
Nanyue Biopharmaceutical
Boya Biopharmaceutical Group
Tonglu Biopharmaceutical
Shandong Taibang Biopharmaceutical
Guangdong Shuanglin Biopharmaceutical
Chengdu Rongsheng Pharmaceutical
Shenzhen Weiguang Biopharmaceutical
Green Cross (China) Biological Products
Sinopharm
Segment by Type
100IU
200IU
400IU
Segment by Application
Measles Prevention
Prevention of Hepatitis B Virus Infection
Hepatitis A Virus Infection
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Human Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Human Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hepatitis B Human Immunoglobulin Market Overview
1.1 Product Overview and Scope of Hepatitis B Human Immunoglobulin
1.2 Hepatitis B Human Immunoglobulin Segment by Type
1.2.1 Global Hepatitis B Human Immunoglobulin Market Value Comparison by Type (2024-2030)
1.2.2 100IU
1.2.3 200IU
1.2.4 400IU
1.3 Hepatitis B Human Immunoglobulin Segment by Application
1.3.1 Global Hepatitis B Human Immunoglobulin Market Value by Application: (2024-2030)
1.3.2 Measles Prevention
1.3.3 Prevention of Hepatitis B Virus Infection
1.3.4 Hepatitis A Virus Infection
1.3.5 Other
1.4 Global Hepatitis B Human Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Human Immunoglobulin Revenue 2019-2030
1.4.2 Global Hepatitis B Human Immunoglobulin Sales 2019-2030
1.4.3 Global Hepatitis B Human Immunoglobulin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hepatitis B Human Immunoglobulin Market Competition by Manufacturers
2.1 Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hepatitis B Human Immunoglobulin Average Price by Manufacturers (2019-2024)
2.4 Global Hepatitis B Human Immunoglobulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis B Human Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis B Human Immunoglobulin, Product Type & Application
2.7 Hepatitis B Human Immunoglobulin Market Competitive Situation and Trends
2.7.1 Hepatitis B Human Immunoglobulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatitis B Human Immunoglobulin Players Market Share by Revenue
2.7.3 Global Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis B Human Immunoglobulin Retrospective Market Scenario by Region
3.1 Global Hepatitis B Human Immunoglobulin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hepatitis B Human Immunoglobulin Global Hepatitis B Human Immunoglobulin Sales by Region: 2019-2030
3.2.1 Global Hepatitis B Human Immunoglobulin Sales by Region: 2019-2024
3.2.2 Global Hepatitis B Human Immunoglobulin Sales by Region: 2025-2030
3.3 Global Hepatitis B Human Immunoglobulin Global Hepatitis B Human Immunoglobulin Revenue by Region: 2019-2030
3.3.1 Global Hepatitis B Human Immunoglobulin Revenue by Region: 2019-2024
3.3.2 Global Hepatitis B Human Immunoglobulin Revenue by Region: 2025-2030
3.4 North America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Hepatitis B Human Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hepatitis B Human Immunoglobulin Sales by Country (2019-2030)
3.4.3 North America Hepatitis B Human Immunoglobulin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Hepatitis B Human Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hepatitis B Human Immunoglobulin Sales by Country (2019-2030)
3.5.3 Europe Hepatitis B Human Immunoglobulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatitis B Human Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Hepatitis B Human Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hepatitis B Human Immunoglobulin Sales by Country (2019-2030)
3.7.3 Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis B Human Immunoglobulin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis B Human Immunoglobulin Sales by Type (2019-2030)
4.1.1 Global Hepatitis B Human Immunoglobulin Sales by Type (2019-2024)
4.1.2 Global Hepatitis B Human Immunoglobulin Sales by Type (2025-2030)
4.1.3 Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2019-2030)
4.2 Global Hepatitis B Human Immunoglobulin Revenue by Type (2019-2030)
4.2.1 Global Hepatitis B Human Immunoglobulin Revenue by Type (2019-2024)
4.2.2 Global Hepatitis B Human Immunoglobulin Revenue by Type (2025-2030)
4.2.3 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2019-2030)
4.3 Global Hepatitis B Human Immunoglobulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hepatitis B Human Immunoglobulin Sales by Application (2019-2030)
5.1.1 Global Hepatitis B Human Immunoglobulin Sales by Application (2019-2024)
5.1.2 Global Hepatitis B Human Immunoglobulin Sales by Application (2025-2030)
5.1.3 Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2019-2030)
5.2 Global Hepatitis B Human Immunoglobulin Revenue by Application (2019-2030)
5.2.1 Global Hepatitis B Human Immunoglobulin Revenue by Application (2019-2024)
5.2.2 Global Hepatitis B Human Immunoglobulin Revenue by Application (2025-2030)
5.2.3 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2019-2030)
5.3 Global Hepatitis B Human Immunoglobulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biotest
6.1.1 Biotest Corporation Information
6.1.2 Biotest Description and Business Overview
6.1.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biotest Hepatitis B Human Immunoglobulin Product Portfolio
6.1.5 Biotest Recent Developments/Updates
6.2 ADMA Biologics
6.2.1 ADMA Biologics Corporation Information
6.2.2 ADMA Biologics Description and Business Overview
6.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Product Portfolio
6.2.5 ADMA Biologics Recent Developments/Updates
6.3 Sanquin Blood
6.3.1 Sanquin Blood Corporation Information
6.3.2 Sanquin Blood Description and Business Overview
6.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Product Portfolio
6.3.5 Sanquin Blood Recent Developments/Updates
6.4 Bio Products Laboratory
6.4.1 Bio Products Laboratory Corporation Information
6.4.2 Bio Products Laboratory Description and Business Overview
6.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Product Portfolio
6.4.5 Bio Products Laboratory Recent Developments/Updates
6.5 Baxter
6.5.1 Baxter Corporation Information
6.5.2 Baxter Description and Business Overview
6.5.3 Baxter Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Baxter Hepatitis B Human Immunoglobulin Product Portfolio
6.5.5 Baxter Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CSL Hepatitis B Human Immunoglobulin Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Hepatitis B Human Immunoglobulin Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Grifols
6.8.1 Grifols Corporation Information
6.8.2 Grifols Description and Business Overview
6.8.3 Grifols Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Grifols Hepatitis B Human Immunoglobulin Product Portfolio
6.8.5 Grifols Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Corporation Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Octapharma Hepatitis B Human Immunoglobulin Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
6.10 Hualan Biological
6.10.1 Hualan Biological Corporation Information
6.10.2 Hualan Biological Description and Business Overview
6.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Product Portfolio
6.10.5 Hualan Biological Recent Developments/Updates
6.11 China Biologic
6.11.1 China Biologic Corporation Information
6.11.2 China Biologic Hepatitis B Human Immunoglobulin Description and Business Overview
6.11.3 China Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 China Biologic Hepatitis B Human Immunoglobulin Product Portfolio
6.11.5 China Biologic Recent Developments/Updates
6.12 Tiantan Biologic
6.12.1 Tiantan Biologic Corporation Information
6.12.2 Tiantan Biologic Hepatitis B Human Immunoglobulin Description and Business Overview
6.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Tiantan Biologic Hepatitis B Human Immunoglobulin Product Portfolio
6.12.5 Tiantan Biologic Recent Developments/Updates
6.13 Shuanglin Bio-pharmacy
6.13.1 Shuanglin Bio-pharmacy Corporation Information
6.13.2 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Description and Business Overview
6.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product Portfolio
6.13.5 Shuanglin Bio-pharmacy Recent Developments/Updates
6.14 Sichuan Yuanda Shuyang
6.14.1 Sichuan Yuanda Shuyang Corporation Information
6.14.2 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Description and Business Overview
6.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product Portfolio
6.14.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.15 Shanghai Institute of Biological
6.15.1 Shanghai Institute of Biological Corporation Information
6.15.2 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Description and Business Overview
6.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product Portfolio
6.15.5 Shanghai Institute of Biological Recent Developments/Updates
6.16 Hualan
6.16.1 Hualan Corporation Information
6.16.2 Hualan Hepatitis B Human Immunoglobulin Description and Business Overview
6.16.3 Hualan Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Hualan Hepatitis B Human Immunoglobulin Product Portfolio
6.16.5 Hualan Recent Developments/Updates
6.17 Shanghai RAAS Blood Products
6.17.1 Shanghai RAAS Blood Products Corporation Information
6.17.2 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Description and Business Overview
6.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product Portfolio
6.17.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.18 China Grand Enterprises
6.18.1 China Grand Enterprises Corporation Information
6.18.2 China Grand Enterprises Hepatitis B Human Immunoglobulin Description and Business Overview
6.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.18.4 China Grand Enterprises Hepatitis B Human Immunoglobulin Product Portfolio
6.18.5 China Grand Enterprises Recent Developments/Updates
6.19 Nanyue Biopharmaceutical
6.19.1 Nanyue Biopharmaceutical Corporation Information
6.19.2 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.19.5 Nanyue Biopharmaceutical Recent Developments/Updates
6.20 Boya Biopharmaceutical Group
6.20.1 Boya Biopharmaceutical Group Corporation Information
6.20.2 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Description and Business Overview
6.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product Portfolio
6.20.5 Boya Biopharmaceutical Group Recent Developments/Updates
6.21 Tonglu Biopharmaceutical
6.21.1 Tonglu Biopharmaceutical Corporation Information
6.21.2 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.21.5 Tonglu Biopharmaceutical Recent Developments/Updates
6.22 Shandong Taibang Biopharmaceutical
6.22.1 Shandong Taibang Biopharmaceutical Corporation Information
6.22.2 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.22.5 Shandong Taibang Biopharmaceutical Recent Developments/Updates
6.23 Guangdong Shuanglin Biopharmaceutical
6.23.1 Guangdong Shuanglin Biopharmaceutical Corporation Information
6.23.2 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.23.5 Guangdong Shuanglin Biopharmaceutical Recent Developments/Updates
6.24 Chengdu Rongsheng Pharmaceutical
6.24.1 Chengdu Rongsheng Pharmaceutical Corporation Information
6.24.2 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.24.5 Chengdu Rongsheng Pharmaceutical Recent Developments/Updates
6.25 Shenzhen Weiguang Biopharmaceutical
6.25.1 Shenzhen Weiguang Biopharmaceutical Corporation Information
6.25.2 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
6.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Portfolio
6.25.5 Shenzhen Weiguang Biopharmaceutical Recent Developments/Updates
6.26 Green Cross (China) Biological Products
6.26.1 Green Cross (China) Biological Products Corporation Information
6.26.2 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Description and Business Overview
6.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product Portfolio
6.26.5 Green Cross (China) Biological Products Recent Developments/Updates
6.27 Sinopharm
6.27.1 Sinopharm Corporation Information
6.27.2 Sinopharm Hepatitis B Human Immunoglobulin Description and Business Overview
6.27.3 Sinopharm Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Sinopharm Hepatitis B Human Immunoglobulin Product Portfolio
6.27.5 Sinopharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis B Human Immunoglobulin Industry Chain Analysis
7.2 Hepatitis B Human Immunoglobulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis B Human Immunoglobulin Production Mode & Process
7.4 Hepatitis B Human Immunoglobulin Sales and Marketing
7.4.1 Hepatitis B Human Immunoglobulin Sales Channels
7.4.2 Hepatitis B Human Immunoglobulin Distributors
7.5 Hepatitis B Human Immunoglobulin Customers
8 Hepatitis B Human Immunoglobulin Market Dynamics
8.1 Hepatitis B Human Immunoglobulin Industry Trends
8.2 Hepatitis B Human Immunoglobulin Market Drivers
8.3 Hepatitis B Human Immunoglobulin Market Challenges
8.4 Hepatitis B Human Immunoglobulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hepatitis B Human Immunoglobulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hepatitis B Human Immunoglobulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hepatitis B Human Immunoglobulin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hepatitis B Human Immunoglobulin Sales (Litre) of Key Manufacturers (2019-2024)
Table 5. Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hepatitis B Human Immunoglobulin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hepatitis B Human Immunoglobulin Average Price (US$/ML) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hepatitis B Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hepatitis B Human Immunoglobulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis B Human Immunoglobulin, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis B Human Immunoglobulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis B Human Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Human Immunoglobulin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis B Human Immunoglobulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hepatitis B Human Immunoglobulin Sales by Region (2019-2024) & (Litre)
Table 18. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2019-2024)
Table 19. Global Hepatitis B Human Immunoglobulin Sales by Region (2025-2030) & (Litre)
Table 20. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2025-2030)
Table 21. Global Hepatitis B Human Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2019-2024)
Table 23. Global Hepatitis B Human Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2025-2030)
Table 25. North America Hepatitis B Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hepatitis B Human Immunoglobulin Sales by Country (2019-2024) & (Litre)
Table 27. North America Hepatitis B Human Immunoglobulin Sales by Country (2025-2030) & (Litre)
Table 28. North America Hepatitis B Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hepatitis B Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hepatitis B Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hepatitis B Human Immunoglobulin Sales by Country (2019-2024) & (Litre)
Table 32. Europe Hepatitis B Human Immunoglobulin Sales by Country (2025-2030) & (Litre)
Table 33. Europe Hepatitis B Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hepatitis B Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2019-2024) & (Litre)
Table 37. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2025-2030) & (Litre)
Table 38. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hepatitis B Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hepatitis B Human Immunoglobulin Sales by Country (2019-2024) & (Litre)
Table 42. Latin America Hepatitis B Human Immunoglobulin Sales by Country (2025-2030) & (Litre)
Table 43. Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Country (2019-2024) & (Litre)
Table 47. Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Country (2025-2030) & (Litre)
Table 48. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hepatitis B Human Immunoglobulin Sales (Litre) by Type (2019-2024)
Table 51. Global Hepatitis B Human Immunoglobulin Sales (Litre) by Type (2025-2030)
Table 52. Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2019-2024)
Table 53. Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2025-2030)
Table 54. Global Hepatitis B Human Immunoglobulin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hepatitis B Human Immunoglobulin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2019-2024)
Table 57. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2025-2030)
Table 58. Global Hepatitis B Human Immunoglobulin Price (US$/ML) by Type (2019-2024)
Table 59. Global Hepatitis B Human Immunoglobulin Price (US$/ML) by Type (2025-2030)
Table 60. Global Hepatitis B Human Immunoglobulin Sales (Litre) by Application (2019-2024)
Table 61. Global Hepatitis B Human Immunoglobulin Sales (Litre) by Application (2025-2030)
Table 62. Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2019-2024)
Table 63. Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2025-2030)
Table 64. Global Hepatitis B Human Immunoglobulin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hepatitis B Human Immunoglobulin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2019-2024)
Table 67. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2025-2030)
Table 68. Global Hepatitis B Human Immunoglobulin Price (US$/ML) by Application (2019-2024)
Table 69. Global Hepatitis B Human Immunoglobulin Price (US$/ML) by Application (2025-2030)
Table 70. Biotest Corporation Information
Table 71. Biotest Description and Business Overview
Table 72. Biotest Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 73. Biotest Hepatitis B Human Immunoglobulin Product
Table 74. Biotest Recent Developments/Updates
Table 75. ADMA Biologics Corporation Information
Table 76. ADMA Biologics Description and Business Overview
Table 77. ADMA Biologics Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 78. ADMA Biologics Hepatitis B Human Immunoglobulin Product
Table 79. ADMA Biologics Recent Developments/Updates
Table 80. Sanquin Blood Corporation Information
Table 81. Sanquin Blood Description and Business Overview
Table 82. Sanquin Blood Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 83. Sanquin Blood Hepatitis B Human Immunoglobulin Product
Table 84. Sanquin Blood Recent Developments/Updates
Table 85. Bio Products Laboratory Corporation Information
Table 86. Bio Products Laboratory Description and Business Overview
Table 87. Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 88. Bio Products Laboratory Hepatitis B Human Immunoglobulin Product
Table 89. Bio Products Laboratory Recent Developments/Updates
Table 90. Baxter Corporation Information
Table 91. Baxter Description and Business Overview
Table 92. Baxter Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 93. Baxter Hepatitis B Human Immunoglobulin Product
Table 94. Baxter Recent Developments/Updates
Table 95. CSL Corporation Information
Table 96. CSL Description and Business Overview
Table 97. CSL Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 98. CSL Hepatitis B Human Immunoglobulin Product
Table 99. CSL Recent Developments/Updates
Table 100. Bayer Corporation Information
Table 101. Bayer Description and Business Overview
Table 102. Bayer Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 103. Bayer Hepatitis B Human Immunoglobulin Product
Table 104. Bayer Recent Developments/Updates
Table 105. Grifols Corporation Information
Table 106. Grifols Description and Business Overview
Table 107. Grifols Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 108. Grifols Hepatitis B Human Immunoglobulin Product
Table 109. Grifols Recent Developments/Updates
Table 110. Octapharma Corporation Information
Table 111. Octapharma Description and Business Overview
Table 112. Octapharma Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 113. Octapharma Hepatitis B Human Immunoglobulin Product
Table 114. Octapharma Recent Developments/Updates
Table 115. Hualan Biological Corporation Information
Table 116. Hualan Biological Description and Business Overview
Table 117. Hualan Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 118. Hualan Biological Hepatitis B Human Immunoglobulin Product
Table 119. Hualan Biological Recent Developments/Updates
Table 120. China Biologic Corporation Information
Table 121. China Biologic Description and Business Overview
Table 122. China Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 123. China Biologic Hepatitis B Human Immunoglobulin Product
Table 124. China Biologic Recent Developments/Updates
Table 125. Tiantan Biologic Corporation Information
Table 126. Tiantan Biologic Description and Business Overview
Table 127. Tiantan Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 128. Tiantan Biologic Hepatitis B Human Immunoglobulin Product
Table 129. Tiantan Biologic Recent Developments/Updates
Table 130. Shuanglin Bio-pharmacy Corporation Information
Table 131. Shuanglin Bio-pharmacy Description and Business Overview
Table 132. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 133. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product
Table 134. Shuanglin Bio-pharmacy Recent Developments/Updates
Table 135. Sichuan Yuanda Shuyang Corporation Information
Table 136. Sichuan Yuanda Shuyang Description and Business Overview
Table 137. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 138. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product
Table 139. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 140. Shanghai Institute of Biological Corporation Information
Table 141. Shanghai Institute of Biological Description and Business Overview
Table 142. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 143. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product
Table 144. Shanghai Institute of Biological Recent Developments/Updates
Table 145. Hualan Corporation Information
Table 146. Hualan Description and Business Overview
Table 147. Hualan Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 148. Hualan Hepatitis B Human Immunoglobulin Product
Table 149. Hualan Recent Developments/Updates
Table 150. Shanghai RAAS Blood Products Corporation Information
Table 151. Shanghai RAAS Blood Products Description and Business Overview
Table 152. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 153. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product
Table 154. Shanghai RAAS Blood Products Recent Developments/Updates
Table 155. China Grand Enterprises Corporation Information
Table 156. China Grand Enterprises Description and Business Overview
Table 157. China Grand Enterprises Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 158. China Grand Enterprises Hepatitis B Human Immunoglobulin Product
Table 159. China Grand Enterprises Recent Developments/Updates
Table 160. Nanyue Biopharmaceutical Corporation Information
Table 161. Nanyue Biopharmaceutical Description and Business Overview
Table 162. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 163. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product
Table 164. Nanyue Biopharmaceutical Recent Developments/Updates
Table 165. Boya Biopharmaceutical Group Corporation Information
Table 166. Boya Biopharmaceutical Group Description and Business Overview
Table 167. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 168. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product
Table 169. Boya Biopharmaceutical Group Recent Developments/Updates
Table 170. Tonglu Biopharmaceutical Corporation Information
Table 171. Tonglu Biopharmaceutical Description and Business Overview
Table 172. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 173. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product
Table 174. Tonglu Biopharmaceutical Recent Developments/Updates
Table 175. Shandong Taibang Biopharmaceutical Corporation Information
Table 176. Shandong Taibang Biopharmaceutical Description and Business Overview
Table 177. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 178. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product
Table 179. Shandong Taibang Biopharmaceutical Recent Developments/Updates
Table 180. Guangdong Shuanglin Biopharmaceutical Corporation Information
Table 181. Guangdong Shuanglin Biopharmaceutical Description and Business Overview
Table 182. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 183. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product
Table 184. Guangdong Shuanglin Biopharmaceutical Recent Developments/Updates
Table 185. Chengdu Rongsheng Pharmaceutical Corporation Information
Table 186. Chengdu Rongsheng Pharmaceutical Description and Business Overview
Table 187. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 188. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product
Table 189. Chengdu Rongsheng Pharmaceutical Recent Developments/Updates
Table 190. Shenzhen Weiguang Biopharmaceutical Corporation Information
Table 191. Shenzhen Weiguang Biopharmaceutical Description and Business Overview
Table 192. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 193. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product
Table 194. Shenzhen Weiguang Biopharmaceutical Recent Developments/Updates
Table 195. Green Cross (China) Biological Products Corporation Information
Table 196. Green Cross (China) Biological Products Description and Business Overview
Table 197. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 198. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product
Table 199. Green Cross (China) Biological Products Recent Developments/Updates
Table 200. Sinopharm Corporation Information
Table 201. Sinopharm Description and Business Overview
Table 202. Sinopharm Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 203. Sinopharm Hepatitis B Human Immunoglobulin Product
Table 204. Sinopharm Recent Developments/Updates
Table 205. Key Raw Materials Lists
Table 206. Raw Materials Key Suppliers Lists
Table 207. Hepatitis B Human Immunoglobulin Distributors List
Table 208. Hepatitis B Human Immunoglobulin Customers List
Table 209. Hepatitis B Human Immunoglobulin Market Trends
Table 210. Hepatitis B Human Immunoglobulin Market Drivers
Table 211. Hepatitis B Human Immunoglobulin Market Challenges
Table 212. Hepatitis B Human Immunoglobulin Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis B Human Immunoglobulin
Figure 2. Global Hepatitis B Human Immunoglobulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hepatitis B Human Immunoglobulin Market Share by Type in 2023 & 2030
Figure 4. 100IU Product Picture
Figure 5. 200IU Product Picture
Figure 6. 400IU Product Picture
Figure 7. Global Hepatitis B Human Immunoglobulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Hepatitis B Human Immunoglobulin Market Share by Application in 2023 & 2030
Figure 9. Measles Prevention
Figure 10. Prevention of Hepatitis B Virus Infection
Figure 11. Hepatitis A Virus Infection
Figure 12. Other
Figure 13. Global Hepatitis B Human Immunoglobulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Hepatitis B Human Immunoglobulin Market Size (2019-2030) & (US$ Million)
Figure 15. Global Hepatitis B Human Immunoglobulin Sales (2019-2030) & (Litre)
Figure 16. Global Hepatitis B Human Immunoglobulin Average Price (US$/ML) & (2019-2030)
Figure 17. Hepatitis B Human Immunoglobulin Report Years Considered
Figure 18. Hepatitis B Human Immunoglobulin Sales Share by Manufacturers in 2023
Figure 19. Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Hepatitis B Human Immunoglobulin Players: Market Share by Revenue in 2023
Figure 21. Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Hepatitis B Human Immunoglobulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Hepatitis B Human Immunoglobulin Sales Market Share by Country (2019-2030)
Figure 24. North America Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Hepatitis B Human Immunoglobulin Sales Market Share by Country (2019-2030)
Figure 28. Europe Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 29. Germany Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Hepatitis B Human Immunoglobulin Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2019-2030)
Figure 36. China Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Hepatitis B Human Immunoglobulin Sales Market Share by Country (2019-2030)
Figure 47. Latin America Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Hepatitis B Human Immunoglobulin Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Hepatitis B Human Immunoglobulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Hepatitis B Human Immunoglobulin by Type (2019-2030)
Figure 57. Global Revenue Market Share of Hepatitis B Human Immunoglobulin by Type (2019-2030)
Figure 58. Global Hepatitis B Human Immunoglobulin Price (US$/ML) by Type (2019-2030)
Figure 59. Global Sales Market Share of Hepatitis B Human Immunoglobulin by Application (2019-2030)
Figure 60. Global Revenue Market Share of Hepatitis B Human Immunoglobulin by Application (2019-2030)
Figure 61. Global Hepatitis B Human Immunoglobulin Price (US$/ML) by Application (2019-2030)
Figure 62. Hepatitis B Human Immunoglobulin Value Chain
Figure 63. Hepatitis B Human Immunoglobulin Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
